NEW YORK (GenomeWeb News) – The Innovative Medicines Initiative, a European public-private funding partnership between the European Commission and the European pharmaceutical industry, plans to spend €156.3 million ($228 million) to support a range of life sciences research.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.